<img height="1" width="1" src="https://www.facebook.com/tr?id=414339248965737&amp;ev=PageView &amp;noscript=1">

Clinical Trial Services for Phase 1-3 Studies

Mobile ophthalmic clinical research support services for challenges associated with each trial phase and protection of ocular endpoints.

Clinical Trial Services | Clinical Trials Phase 1-3

Why Phase 1–3 Clinical Trials Fail or Slow Down

Phase 1, 2, and 3 programs can stall due to slow site activation, limited patient access, and uneven protocol execution. Traditional clinical trial services can struggle in this area, resulting in delays, missed endpoints, and increased regulatory risk.

At 20/20 Onsite, our clinical research support services are tailored to each protocol. We align delivery modality, assessment schedule, and onsite oversight to your endpoints and regulatory expectations.

How the right clinical trial services speed up timelines:

  • Site activation: Standardized SOPs, trained staff, and validated equipment accelerate readiness.

  • Patient access: Point-of-need delivery brings assessments to patients, boosting enrollment, diversity, and retention.

  • Protocol variability: Harmonized workflows and QA protect data integrity across sites.

  • Operational complexity: Integrated onsite clinical trial management reduces sponsor/CRO coordination burden.

If you’re evaluating clinical research solutions choose a partner that delivers quality at speed without sacrificing compliance.

Keeping clinical trials on track with patient-centric, point-of-need clinical research solutions

20/20 Onsite delivers comprehensive clinical trial services for Phase 1, Phase 2, and Phase 3 studies through our innovative mobile research model. Our clinical research support services revolutionize traditional fixed-location sites by bringing state-of-the-art ophthalmic assessments directly to participants wherever they are. 
20/20 Onsite Ophthalmic Clinical Trial Solutions Clinical Trials Phase 1-3

Prescreening and Enrollment

 We expand access to diverse participants through our clinical research support services and make pre-screening visits easy for patients. 

20/20 Onsite Ophthalmic Clinical Trial Solutions Clinical Trials Phase 1-3

Patient Retention

Remove barriers to ongoing study participation and decrease the risk of losing enrolled patients through on-site clinical trial management. 
20/20 Onsite Ophthalmic Clinical Trial Solutions Clinical Trials Phase 1-3

Ocular Endpoint Protection

 Ensure accuracy, consistency, and regulatory confidence with expert ocular endpoint protection through specialized clinical trial support. 

Phase 1

Clinical Trial Support with Rapid, Reliable Ocular Assessments

In Phase 1, speed is critical, yet protocols increasingly require specialized safety assessments, including ophthalmic exams, that can delay site readiness and limit participant throughput. Traditional clinical trial site services often struggle to mobilize quickly or adapt to protocol-specific ophthalmic needs, especially when working with healthy volunteers who may not be near academic centers.

How Our Clinical Research Support Services Help:
20/20 Onsite brings point-of-need ophthalmic exam directly to your Phase 1 unit or CRO partner site, reducing delays in site activation. Clinical professionals staff our mobile vision clinics with an average of 11+ years of ophthalmic experience, capable of executing protocol-specific assessments (e.g., visual acuity, fundus photography, OCT) with rapid deployment and standardized data capture.

Our clinical research solutions help sponsors meet aggressive timelines while ensuring that early safety signals are captured with precision through specialized Phase 1 clinical trial support. 

Learn More About Phase 1 Clinical Trial Services

Phase 2

Supporting Protocol Refinement with Patient-Centric Clinical Research Solutions

Phase 2 studies often suffer from protocol complexity and increased imaging demands, particularly for ophthalmic endpoints. Patient recruitment slows when eligible participants must travel to limited fixed locations for specialized assessments. This increases screen failure rates and stalls timeline projections in phase 2 clinical trials.

How Our Clinical Trial Services Help:
With full-service mobile vision units and centralized coordination,  20/20 Onsite enables protocol-required ophthalmic imaging through point-of-care clinical research, improving access, retention, and adherence. We support refined endpoint execution (e.g., slit lamp, lens exams, IOP, fundus exams) with quality-controlled data and site-agnostic deployment.

Our clinical research support services team collaborates with clinical operations to identify recruitment bottlenecks and deploy point-of-need assessments strategically to maximize enrollment efficiency without compromising data integrity.

Read Our Phase 2 Case Studies

Phase 3

Reducing Operational Complexity with Scalable Clinical Trial Services

Phase 3 trials demand scalability, consistency, and rigorous adherence to SOPs across dozens or even hundreds of sites. Coordinating ophthalmic assessments at scale is logistically intensive and prone to variability, especially when outsourcing to local providers with inconsistent equipment, bandwidth, or expertise.

How Our Clinical Research Solutions Help:
20/20 Onsite scales with your phase 1, 2, or 3 clinical trials, ensuring uniform, protocol-compliant ophthalmic assessments regardless of location. Our mobile clinical trial units are equipped with standardized instrumentation and can handle complex protocols to ensure data comparability across all visits. With nationwide coverage and a robust data infrastructure, our clinical trial site services help sponsors reduce site burden, ensure audit-readiness, and protect data quality, while improving patient retention through convenient point-of-care clinical assessments.

Whether your trial spans urban hubs or underserved regions, we deliver high-quality assessments through comprehensive clinical trial services at the point of need. 

Take a Virtual Tour of Our Mobile Vision Clinic

20/20 Onsite: Comprehensive Clinical Trial Services for Phase 1-3 

While working with 20/20 Onsite for previous and current studies, we have been able to provide ophthalmological services that were previously not feasible for our clinical units. Doing so has been very successful in providing safety and ophthalmological oversight of study participants – as required by good clinical practices and the sponsor protocol. Dr. David Wyatt, Vice-President and Global Medical Lead, Syneos Health

Proven Results from Our Clinical Trial Services

Point of Need

100%

Screening timelines met across all business operations.

Data Integrity

98%

Data accuracy submission rate.

Patient Retention

91%

Patient retention rate vs industry standard 70%.

Patient Centricity

95+

Patient Net Promotor Score vs industry average NPS of 30-50.


Clinical Case Studies

20/20 Onsite Point-of-need clinical trial ophthalmic assessments and solutions - Clinical Trials Phase 1-3

Streamlining a Clinical Study for Syneos Health

20/20 Onsite Point-of-need clinical trial ophthalmic assessments and solutions - Clinical Trials Phase 1-3

Enhancing Phase 1 Clinical Trials with Point-of-Need Safety Assessments

20/20 Onsite Point-of-need clinical trial ophthalmic assessments and solutions - Clinical Trials Phase 1-3

Optimizing Non-Ophthalmic Phase 3 Trials with Point-of-Need Eye Assessments

20/20 Onsite Point-of-need clinical trial ophthalmic assessments and solutions - Clients Vertex
20/20 Onsite Point-of-need clinical trial ophthalmic assessments and solutions - Clients Biogen
20/20 Onsite Point-of-need clinical trial ophthalmic assessments and solutions - Clients Syneos
20/20 Onsite Point-of-need clinical trial ophthalmic assessments and solutions - Clients Pega
20/20 Onsite Point-of-need clinical trial ophthalmic assessments and solutions - Clients AGTC
20/20 Onsite Point-of-need clinical trial ophthalmic assessments and solutions - Clients Blue Bird Bio
20/20 Onsite Point-of-need clinical trial ophthalmic assessments and solutions - Clients Boston Public Schools
20/20 Onsite Point-of-need clinical trial ophthalmic assessments and solutions - Clients City of Boston

FAQs: 20/20 Onsite's Phase 1-3 Clinical Trial Support Services

Ready to start a conversation about 20/20 Onsite's solutions for Phase 1-3?

Contact 20/20 Onsite today to learn how our clinical trial services can accelerate your Phase 1-3 research studies while improving participant experience and data quality. 

Employers or patients, contact us here.